ArticlePharmaceutics2025

Ferroptosis Among the Antiproliferative Pathways Activated by a Lipophilic Ruthenium(III) Complex as a Candidate Drug for Triple-Negative Breast Cancer.

Maria Grazia Ferraro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.